Please provide your email address to receive an email when new articles are posted on . CHICAGO — Trulance safely and effectively improved symptoms in patients with constipation-predominant irritable ...
Synergy Pharmaceuticals has received FDA approval for Trulance (plecanatide), a treatment for adult chronic idiopathic constipation. Chronic idiopathic constipation describes patients who experience ...
New York City-based Synergy Pharmaceuticals submitted a supplemental New Drug Application for Trulance. Here’s what you should know. 1. Trulance was FDA approved in adults with chronic idiopathic ...
Ahead of the fourth quarter showcase from Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) anticipated March 7 th, first comes a PDUFA date of FDA judgment for Trulance. As approval waits in the wings ...
What’s the poop? A new emoji keyboard from Synergy Pharmaceuticals, that's what, as the drugmaker launches its latest chronic idiopathic constipation campaign. Synergy, which won approval for its new ...
The chronic idiopathic constipation (CIC) market has a new entrant. This was occasioned by the FDA’s approval of Trulance from Synergy Pharmaceuticals Inc (NASDAQ:SGYP). The agency’s move triggers ...
Synergy Pharmaceuticals Inc SGYP presented positive results from its Phase 3 study of plecanatide for the treatment of irritable bowel syndrome with constipation (IBS-C). In two large studies, Synergy ...
Please provide your email address to receive an email when new articles are posted on . At 12 weeks, significant improvements in overall PAC-QoL and IBS-QoL scores favored plecanatide over placebo.
The sNDA was based on two Phase 3 studies that included over 2,000 individuals with IBS-C Synergy announced that the Food and Drug Administration (FDA) has accepted the supplemental New Drug ...
Synergy Pharmaceuticals Inc.SGYP announced that the FDA has approved one of its lead pipeline candidates, Trulance (plecanatide), for the treatment of adults suffering from chronic idiopathic ...
Synergy Pharmaceuticals has reportedly made waves in the GI market already, by poaching a slew of reps from troubled Valeant. And as Synergy's launch for Trulance approaches, it’s getting ready to ...
BRIDGEWATER, N.J., June 15, 2021 /PRNewswire/ -- Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results